Prescription Drugs and the Elderly: Many Still Receive Potentially Harmful Drugs Despite Recent Improvements Testimony. Statement of Sarah F. Jaggar, Director Health Financing and Public Health Issues; Health, Education, and Human Services Division Before the Special Committee on Aging, U.S. Senate
Washington, DC: GAO [GAO/T-HEHS-96-114], 1996 March 28; 6p.
Showing items related by title, author, creator and subject.
Prescription Drugs: Prices and Regulation in Canada and Europe (Statement by Sarah F. Jaggar, Director of Health Financing and Policy Issues, Before the Senate Committee on Governmental Affairs) Jaggar, Sarah F. (United States. General Accounting Office, 1994-07-27)
Prescription Drug Benefits: Applying Private Sector Management Methods to Medicare. Statement of William J. Scanlon, Director Health Financing and Public Health Issues, Health, Education, and Human Services Division. Testimony Before The Committee on Finance, U.S. Senate Unknown author (United States. General Accounting Office [GAO], 2000-03-22)